Prosecution Insights
Prosecution Insights
199 pending office actions • 68 clients • 169 examiners • 95 art units • 0 of 199 (0%) have an AI response strategy ready • 358 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 198 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 198 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 5 (3%) |
| §103 only | 121 (61%) |
| §102 only | 16 (8%) |
| §112 only | 20 (10%) |
| No statute on record | 37 (19%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITESELL, STEVEN H | 5 | 81.8% | +13.3% |
| BRISTOL, LYNN ANNE | 4 | 63.7% | +39.7% |
| CHATTIN, AMY MARIE | 3 | 74.3% | +39.1% |
| BEHARRY, ZANNA MARIA | 3 | 23.3% | +54.0% |
| MENDOZA, ALEXANDRIA ARELLANO | 2 | 70.0% | +42.9% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 2 | 50.4% | +41.3% |
| CARLSON, JOSHUA MICHAEL | 2 | 59.7% | +36.9% |
| KIM, PETER B | 2 | 82.8% | +9.1% |
| BELYAVSKYI, MICHAIL A | 2 | 63.8% | +27.5% |
| EISEMAN, ADAM JARED | 2 | 55.0% | +26.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426860 | PROJECTION EXPOSURE APPARATUS FOR SEMICONDUCTOR LITHOGRAPHY HAVING A CONNECTING ELEMENT | KIM, PETER B | 58d overdue |
| 18503693 | HEATING ARRANGEMENT AND METHOD FOR HEATING AN OPTICAL ELEMENT | WHITESELL, STEVEN H | 8d overdue |
| 18895292 | DRIVE DEVICE, OPTICAL SYSTEM AND LITHOGRAPHY APPARATUS | WHITESELL, STEVEN H | 5d overdue |
| 18426549 | METHOD AND APPARATUS FOR DETERMINING OPTICAL PROPERTIES OF DEPOSITION MATERIALS USED FOR LITHOGRAPHIC MASKS | KIM, PETER B | 14d |
| 18899247 | CONTROL DEVICE, OPTICAL SYSTEM, LITHOGRAPHY INSTALLATION AND METHOD | WHITESELL, STEVEN H | 16d |
| 18362630 | METHOD FOR PRODUCING A MULTI-PART MIRROR OF A PROJECTION ILLUMINATION SYSTEM FOR MICROLITHOGRAPHY | WHITESELL, STEVEN H | 29d |
| 18507893 | PROJECTION EXPOSURE APPARATUS AND METHOD FOR DESIGNING A COMPONENT OF A PROJECTION EXPOSURE APPARATUS | WHITESELL, STEVEN H | 84d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17430822 | Treating Heart Failure | BEHARRY, ZANNA MARIA | 100d overdue |
| 18544841 | CLEANING COMPOSITIONS AND METHODS OF USE THEREOF | PAUL, SHREYA | 50d overdue |
| 17428593 | PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS | BEHARRY, ZANNA MARIA | 31d overdue |
| 18503936 | Highly Sensitive EGFRvIII Detection | KIM, YOUNG J | 17d overdue |
| 17626728 | ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF | BEHARRY, ZANNA MARIA | 9d overdue |
| 18072947 | Universal Wall Boundary Condition Treatment for K-Omega Turbulence Models | HANN, JAY B | 7d |
| 18670858 | METHOD AND DEVICE FOR ANALYSING AN IMAGE OF A MICROLITHOGRAPHIC MICROSTRUCTURED SAMPLE | RIVERA-MARTINEZ, GUILLERMO M | 20d |
| 16193272 | Collateral Mechanisms Using High Quality Redeemable Notes | SCHWARZENBERG, PAUL | 27d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18371626 | DOSAGE REGIMENS FOR PARP7 INHIBITORS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 317d overdue |
| 16692676 | ANTIGEN-BINDING MOLECULE HAVING REGULATED CONJUGATION BETWEEN HEAVY-CHAIN AND LIGHT-CHAIN | BRISTOL, LYNN ANNE | 104d overdue |
| 17430822 | Treating Heart Failure | BEHARRY, ZANNA MARIA | 100d overdue |
| 17777659 | STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY | CHATTIN, AMY MARIE | 91d overdue |
| 17428593 | PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS | BEHARRY, ZANNA MARIA | 31d overdue |
| 18820383 | DYNAMIC INTERFEROMETER ILLUMINATOR | MENDOZA, ALEXANDRIA ARELLANO | 30d overdue |
| 18539672 | POSTPARTUM HEMORRHAGE COLLECTION DEVICE | EISEMAN, ADAM JARED | 28d overdue |
| 18587228 | METHOD AND MEASURING DEVICE FOR INSPECTING PHOTOMASKS, AND EUV CAMERA | CARLSON, JOSHUA MICHAEL | 24d overdue |
| Art Unit | Apps |
|---|---|
| 1643 | 12 |
| 1644 | 7 |
| 1636 | 7 |
| 1759 | 5 |
| 2881 | 5 |
| 1618 | 5 |
| 2877 | 4 |
| 2882 | 4 |
| 1622 | 4 |
| 3791 | 4 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19126922 | FAULT DETECTION IN AN ELECTRIC DRIVE TRAIN OF A VEHICLE | Mclaren Applied Limited | PATEL, PARESH H | 2858 | §112 | Non-Final OA | 14d | Pending | May 02, 2025 |
| 19170372 | METHOD FOR COATING A SUBSTRATE | Carl Zeiss Smt GmbH | BERMAN, JASON | 1794 | §103 | Non-Final OA | 34d | Pending | Apr 04, 2025 |
| 19058792 | TRACKING AND MANEUVERING USING AN ELECTROMAGNETIC SENSOR | Northern Digital Inc. | SABOKTAKIN, MARJAN | 3797 | §102 | Non-Final OA | 56d overdue | Pending | Feb 20, 2025 |
| 19000886 | SECURE ZERO KNOWLEDGE DATA TRANSFORMATION AND VALIDATION | Lo3 Energy Inc. | VU, BAI DUC | 2163 | §112 | Final Rejection | 22d | Pending | Dec 24, 2024 |
| 18934169 | COMPOUNDS AND METHODS FOR USING GALLOYLATED POLYPHENOLS TO TREAT DISEASES MEDIATED BY THIOL ISOMERASES | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | GONZALEZ, LUISALBERTO | 1624 | §102 | Non-Final OA | 27d | Pending | Oct 31, 2024 |
| 18899247 | CONTROL DEVICE, OPTICAL SYSTEM, LITHOGRAPHY INSTALLATION AND METHOD | Carl Zeiss Smt GmbH | WHITESELL, STEVEN H | 1759 | §112 | Non-Final OA | 16d | Pending | Sep 27, 2024 |
| 18895292 | DRIVE DEVICE, OPTICAL SYSTEM AND LITHOGRAPHY APPARATUS | Carl Zeiss Smt GmbH | WHITESELL, STEVEN H | 1759 | §112 | Non-Final OA | 5d overdue | Pending | Sep 24, 2024 |
| 18820383 | DYNAMIC INTERFEROMETER ILLUMINATOR | Zygo Corporation | MENDOZA, ALEXANDRIA ARELLANO | 2877 | §103 | Non-Final OA | 30d overdue | Pending | Aug 30, 2024 |
| 18809561 | DIELECTRIC FILM-FORMING COMPOSITION | Fujifilm Electronic Materials U.S.A., Inc. | CAI, WENWEN | 1763 | Other | Non-Final OA | 13d | Pending | Aug 20, 2024 |
| 18775344 | METHOD FOR DETERMINING A LOCATION OF AN OBJECT SURFACE | Carl Zeiss Smt GmbH | ASFAW, MESFIN T | 2882 | §102 | Non-Final OA | 32d overdue | Pending | Jul 17, 2024 |
| 18759374 | INTERFACE FOR ROUTING DATA TRANSMISSIONS IN RESPONSE TO DYNAMIC QUEUING OF SERVICE REQUESTS | American Well Corporation | TOKARCZYK, CHRISTOPHER B | 3687 | §103 | Final Rejection | 72d overdue | Pending | Jun 28, 2024 |
| 18671515 | THREE-DIMENSIONAL DISPLAYS USING ELECTROMAGNETIC FIELD COMPUTATIONS | Pacific Light & Hologram, Inc. | YANG, ANDREW GUS | 2614 | §103 | Non-Final OA | 2d overdue | Pending | May 22, 2024 |
| 18670858 | METHOD AND DEVICE FOR ANALYSING AN IMAGE OF A MICROLITHOGRAPHIC MICROSTRUCTURED SAMPLE | Carl Zeiss Smt GmbH | RIVERA-MARTINEZ, GUILLERMO M | 2677 | §101 | Non-Final OA | 20d | Pending | May 22, 2024 |
| 18669947 | EXERCISE MACHINE BRAKE SYSTEM | Hydrow, Inc. | ANDERSON, MEGAN M | 3784 | §103 | Non-Final OA | 16d | Pending | May 21, 2024 |
| 18709840 | VASECTOMY REVERSAL DEVICE | Male Fertility And Peyronies'S Clinic Pllc | RWEGO, KANKINDI | 3771 | §103 | Non-Final OA | 30d | Pending | May 14, 2024 |
| 18654312 | DOSAGE REGIMENS FOR PARP7 INHIBITORS | Ribon Therapeutics, Inc. | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | 1d overdue | Pending | May 03, 2024 |
| 18648561 | OPTICAL SYSTEM FOR A METROLOGY SYSTEM AND METROLOGY SYSTEM WITH SUCH AN OPTICAL SYSTEM | Carl Zeiss Smt GmbH | PERSAUD, DEORAM | 2882 | §103 | Non-Final OA | 10d overdue | Pending | Apr 29, 2024 |
| 18648644 | OPTICAL SYSTEM FOR A METROLOGY SYSTEM AND METROLOGY SYSTEM WITH SUCH AN OPTICAL SYSTEM | Carl Zeiss Smt GmbH | MENDOZA, ALEXANDRIA ARELLANO | 2877 | §103 | Non-Final OA | 12d | Pending | Apr 29, 2024 |
| 18644176 | Prediction of Mechanical Properties of Sedimentary Rocks based on a Grain to Grain Parametric Cohesive Contact Model | DASSAULT SYSTEMES | RICHER, AARON M | 2617 | Other | Non-Final OA | 28d | Pending | Apr 24, 2024 |
| 18624734 | METHODS OF DELIVERING AN AGENT TO THE EYE | Massachusetts Eye And Ear Infirmary | SU, SUSAN SHAN | 3781 | §103 | Non-Final OA | 8d overdue | Pending | Apr 02, 2024 |
| 18616337 | CLEANING COMPOSITIONS AND METHODS OF USE THEREOF | Fujifilm Electronic Materials U.S.A. , Inc. | BOYER, CHARLES I | 1761 | §103 | Non-Final OA | 48d | Pending | Mar 26, 2024 |
| 18611374 | APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF | Massachusetts Eye And Ear Infirmary | WANG, CHANG YU | 1675 | §112 | Non-Final OA | 84d | Pending | Mar 20, 2024 |
| 18607874 | Rapidly Cooling Food and Drinks | Coldsnap, Corp. | ZERPHEY, CHRISTOPHER R | 3799 | §103 | Non-Final OA | 87d overdue | Pending | Mar 18, 2024 |
| 18608369 | ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY | Chugai Seiyaku Kabushiki Kaisha | O DELL, DAVID K | 1621 | Other | Final Rejection | 112d overdue | Pending | Mar 18, 2024 |
| 18598030 | ILLUMINATED MAGNET SAFE RETRACTORS AND OTHER MEDICAL DEVICES | Coopersurgical, Inc. | JOHANAS, JACQUELINE T | 3773 | §103 | Non-Final OA | 140d overdue | Pending | Mar 07, 2024 |
| 18594428 | DISTRIBUTED LEDGER FOR PHYSICAL MATERIAL | Mat International Holdings, LLC | CHOI, YUE YIN | 3699 | §103 | Non-Final OA | 12d | Pending | Mar 04, 2024 |
| 18587228 | METHOD AND MEASURING DEVICE FOR INSPECTING PHOTOMASKS, AND EUV CAMERA | Carl Zeiss Smt GmbH | CARLSON, JOSHUA MICHAEL | 2877 | Other | Non-Final OA | 24d overdue | Pending | Feb 26, 2024 |
| 18682548 | TARGETING 3-KETODIHYDROSPHINGOSINE REDUCTASE (KDSR) IN CANCER | UNIVERSITY OF MASSACHUSETTS | YAMASAKI, ROBERT J | 1657 | §103 | Non-Final OA | 42d | Pending | Feb 09, 2024 |
| 18426860 | PROJECTION EXPOSURE APPARATUS FOR SEMICONDUCTOR LITHOGRAPHY HAVING A CONNECTING ELEMENT | Carl Zeiss Smt GmbH | KIM, PETER B | 2882 | §112 | Non-Final OA | 58d overdue | Pending | Jan 30, 2024 |
| 18426549 | METHOD AND APPARATUS FOR DETERMINING OPTICAL PROPERTIES OF DEPOSITION MATERIALS USED FOR LITHOGRAPHIC MASKS | Carl Zeiss Smt GmbH | KIM, PETER B | 2882 | §103 | Non-Final OA | 14d | Pending | Jan 30, 2024 |
| 18421826 | METHODS FOR MANUFACTURING T CELLS EXPRESSING OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS | City Of Hope | BELYAVSKYI, MICHAIL A | 1644 | §103 | Final Rejection | 72d | Pending | Jan 24, 2024 |
| 18419639 | Surface Treatment Compositions and Methods | Fujifilm Electronic Materials U.S.A., Inc. | MARKOFF, ALEXANDER | 1711 | §103 | Non-Final OA | 3d overdue | Pending | Jan 23, 2024 |
| 18419940 | APPARATUS FOR ANALYSING AND/OR PROCESSING A SAMPLE WITH A PARTICLE BEAM AND METHOD | Carl Zeiss Smt GmbH | MCCORMACK, JASON L | 2881 | §103 | Non-Final OA | 20d | Pending | Jan 23, 2024 |
| 18415999 | Increasing Specificity for RNA-Guided Genome Editing | The General Hospital Corporation | HUDSON, AMY ROSE | 1636 | §103 | Final Rejection | 28d overdue | Pending | Jan 18, 2024 |
| 18410029 | MODULAR STATOR FOR PROGRESSIVE CAVITY DEVICES | Roper Pump Company LLC | OMGBA, ESSAMA | 3746 | §103 | Non-Final OA | 9d | Pending | Jan 11, 2024 |
| 18406448 | METHOD FOR DEFECT DETECTION IN A SEMICONDUCTOR SAMPLE IN SAMPLE IMAGES WITH DISTORTION | Carl Zeiss Multisem GmbH | VO, QUANG N | 2683 | §103 | Non-Final OA | 46d overdue | Pending | Jan 08, 2024 |
| 18575143 | CALIBRATING AN ULTRASOUND APPARATUS USING MATRIX-MATRIX THROUGH TRANSMISISON | Dolphitech AS | NIA, FATEMEH ESFANDIARI | 2855 | §103 | Non-Final OA | 31d overdue | Pending | Dec 28, 2023 |
| 18575109 | CALIBRATING AN ULTRASOUND APPARATUS | Dolphitech AS | HAMMOND III, THOMAS M | 2855 | §103 | Non-Final OA | 36d overdue | Pending | Dec 28, 2023 |
| 18545377 | DYNAMIC FORMAT ELECTRONIC CONFIRMATIONS | Onecore Global | MACCAGNO, PIERRE L | 3687 | §112 | Final Rejection | 147d overdue | Pending | Dec 19, 2023 |
| 18544841 | CLEANING COMPOSITIONS AND METHODS OF USE THEREOF | Fujifilm Electronic Materials U.S.A., Inc. | PAUL, SHREYA | 1761 | §101 | Non-Final OA | 50d overdue | Pending | Dec 19, 2023 |
| 18571154 | METHODS TO CHARACTERIZE FUNCTIONAL AND DYSFUNCTIONAL ACUTE INFLAMMATORY RESPONSES TO PATHOLOGIC PROCESSES | The General Hospital Corporation | HOLCOMB, MARK | 3685 | §103 | Non-Final OA | 56d overdue | Pending | Dec 15, 2023 |
| 18539672 | POSTPARTUM HEMORRHAGE COLLECTION DEVICE | Coopersurgical, Inc. | EISEMAN, ADAM JARED | 3791 | §103 | Non-Final OA | 28d overdue | Pending | Dec 14, 2023 |
| 18539592 | POSTPARTUM HEMORRHAGE MONITORING DEVICE AND METHODS | Coopersurgical, Inc. | EISEMAN, ADAM JARED | 3791 | §103 | Non-Final OA | 23d overdue | Pending | Dec 14, 2023 |
| 18566929 | INHIBITORS OF TTBK1 | DANA-FARBER CANCER INSTITUTE, INC. | SHIM, DAVID M. | 1626 | §112 | Non-Final OA | 19d overdue | Pending | Dec 04, 2023 |
| 18511486 | Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules | The General Hospital Corporation | WANG, RUIXUE | 1632 | §103 | Non-Final OA | 75d | Pending | Nov 16, 2023 |
| 18389410 | Integrity Testing Method and Apparatus for Delivering Vapor to the Uterus | Aegea Medical Inc. | FERNANDES, PATRICK M | 3791 | Other | Non-Final OA | 53d | Pending | Nov 14, 2023 |
| 18507893 | PROJECTION EXPOSURE APPARATUS AND METHOD FOR DESIGNING A COMPONENT OF A PROJECTION EXPOSURE APPARATUS | Carl Zeiss Smt GmbH | WHITESELL, STEVEN H | 1759 | §103 | Final Rejection | 84d | Pending | Nov 13, 2023 |
| 18507709 | Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity | The General Hospital Corporation | LEE, JAE W | 1656 | Other | Final Rejection | 19d | Pending | Nov 13, 2023 |
| 18560000 | Methods and Compositions for Extending Organ and Tissue Preservation | The General Hospital Corporation | VAN BUREN, LAUREN K | 1638 | Other | Non-Final OA | 10d overdue | Pending | Nov 09, 2023 |
| 18503936 | Highly Sensitive EGFRvIII Detection | The General Hospital Corporation | KIM, YOUNG J | 1681 | §101 | Non-Final OA | 17d overdue | Pending | Nov 07, 2023 |
| 18503693 | HEATING ARRANGEMENT AND METHOD FOR HEATING AN OPTICAL ELEMENT | Carl Zeiss Smt GmbH | WHITESELL, STEVEN H | 1759 | §103 | Final Rejection | 8d overdue | Pending | Nov 07, 2023 |
| 18503458 | Optical Fiber Shape Sensing | Northern Digital Inc. | RAHLL, JERRY T | 2874 | §103 | Non-Final OA | 4d overdue | Pending | Nov 07, 2023 |
| 18501863 | MULTI-BEAM MICROSCOPE AND METHOD FOR OPERATING A MULTI-BEAM MICROSCOPE USING SETTINGS ADJUSTED TO AN INSPECTION SITE | Carl Zeiss Multisem GmbH | KIM, ROBERT H | 2881 | §103 | Non-Final OA | 5d | Pending | Nov 03, 2023 |
| 18382090 | Packaging Systems for Implantable Devices and Related Methods | Coopersurgical, Inc. | ACKUN, JACOB K | 3736 | §102 | Non-Final OA | 139d overdue | Pending | Oct 20, 2023 |
| 18482504 | Brewing and Cooling a Beverage | Coldsnap, Corp. | DUKE, EMMANUEL E | 3763 | §102 | Final Rejection | 132d overdue | Pending | Oct 06, 2023 |
| 18285636 | CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME | Gc Cell Corporation | CHATTIN, AMY MARIE | 1643 | Other | Non-Final OA | 9d overdue | Pending | Oct 04, 2023 |
| 18285634 | CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND NATURAL KILLER CELLS COMPRISING THE SAME | Gc Cell Corporation | CHATTIN, AMY MARIE | 1643 | §103 | Non-Final OA | 8d overdue | Pending | Oct 04, 2023 |
| 18480574 | Method for Automatically Converting a Text string to an Interactive Video Experience | Allego, Inc. | HE, JIALONG | 2659 | §103 | Final Rejection | 86d overdue | Pending | Oct 04, 2023 |
| 18480730 | ANTIGEN-BINDING MOLECULE PROMOTING DISAPPEARANCE OF ANTIGENS HAVING PLURALITY OF BIOLOGICAL ACTIVITIES | Chugai Seiyaku Kabushiki Kaisha | LANDSMAN, ROBERT S | 1647 | Other | Non-Final OA | 26d overdue | Pending | Oct 04, 2023 |
| 18284637 | SUBMUCOSAL IMPLANTABLE DRUG DELIVERY APPARATUSES, SYSTEMS, AND METHODS | Massachusetts Eye And Ear Infirmary | BURKE, THOMAS P | 3741 | §103 | Non-Final OA | 5d | Pending | Sep 28, 2023 |
| 18284413 | CAR T CELL THERAPY AND IFN GAMMA | City Of Hope | LEE, YIE CHIA | 1642 | §103 | Non-Final OA | 9d | Pending | Sep 27, 2023 |
| 18371626 | DOSAGE REGIMENS FOR PARP7 INHIBITORS | Ribon Therapeutics, Inc. | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | Other | Non-Final OA | 317d overdue | Pending | Sep 22, 2023 |
| 18471357 | Chimeric Antigen Receptor Specific for Folate Receptor 1 | Miltenyi Biotec B.V. & Co. KG | STONEBRAKER, ALYSSA RAE | 1642 | §103 | Non-Final OA | 45d overdue | Pending | Sep 21, 2023 |
| 18367208 | Mesh Integrity Check | Carl Zeiss Smt GmbH | CARLSON, JOSHUA MICHAEL | 2877 | §103 | Non-Final OA | 23d overdue | Pending | Sep 12, 2023 |
| 18280970 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF MYASTHENIA GRAVIS | Hoffmann-La Roche, Inc. | NICKOL, GARY B | 1643 | Other | Non-Final OA | 20d | Pending | Sep 08, 2023 |
| 18279162 | COMPOUNDS FOR BRAIN IMAGING | The General Hospital Corporation | BAEK, JONGHWAN NMN | 1618 | §103 | Non-Final OA | 83d | Pending | Aug 28, 2023 |
| 18456304 | GAS INJECTION SUBSYSTEM FOR USE IN AN INSPECTION SYSTEM TO INSPECT A SAMPLE BY USE OF CHARGED PARTICLES AND INSPECTION SYSTEM HAVING SUCH GAS INJECTION SUBSYSTEM | Carl Zeiss Smt GmbH | CHOI, JAMES J | 2878 | §103 | Non-Final OA | 16d overdue | Pending | Aug 25, 2023 |
| 18278903 | MICRONEEDLES AND METHODS FOR TREATING THE SKIN | Massachusetts Institute Of Technology | MEYERS, ELIZABETH ANNE | 1617 | Other | Non-Final OA | 5d | Pending | Aug 25, 2023 |
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | The Brigham And Women`S Hospital, Inc. | SHIAO, REI TSANG | 1691 | §103 | Final Rejection | 70d | Pending | Aug 21, 2023 |
| 18276540 | Pectin Compositions and Methods of Use | The Brigham And Women`S Hospital, Inc. | CHANG, KYUNG SOOK | 1613 | §103 | Non-Final OA | 3d overdue | Pending | Aug 09, 2023 |
| 18363126 | FROZEN PROTEIN SHAKES | Coldsnap, Corp. | SMITH, CHAIM A | 1791 | Other | Non-Final OA | 71d overdue | Pending | Aug 01, 2023 |
| 18275146 | METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS IN THE INNER EAR OF ADULT MAMMALS | Massachusetts Eye And Ear Infirmary | ZAHORIK, AMANDA MARY | 1636 | §103 | Non-Final OA | 24d overdue | Pending | Jul 31, 2023 |
| 18362630 | METHOD FOR PRODUCING A MULTI-PART MIRROR OF A PROJECTION ILLUMINATION SYSTEM FOR MICROLITHOGRAPHY | Carl Zeiss Smt GmbH | WHITESELL, STEVEN H | 1759 | §103 | Final Rejection | 29d | Pending | Jul 31, 2023 |
| 18227215 | METHODS AND SYSTEMS FOR MANAGING DIABETES | Joslin Diabetes Center, Inc. | PONTON, JAMES D | 3783 | §103 | Non-Final OA | 83d | Pending | Jul 27, 2023 |
| 18274641 | FC-ENHANCED ANTIBODIES FOR PREVENTION AND TREATMENT OF EBOLA VIRUS INFECTION | The General Hospital Corporation | ALLEN, MICHAEL D | 1671 | §103 | Non-Final OA | 42d | Pending | Jul 27, 2023 |
| 18273200 | NOVEL BICYCLIC PEPTIDES | The Queensland Institute of Medical Research | BOWLES, DAVID PAUL | 1654 | §112 | Non-Final OA | 25d overdue | Pending | Jul 19, 2023 |
| 18350522 | OPTICAL ELEMENT FOR REFLECTING RADIATION, AND OPTICAL ASSEMBLY | Carl Zeiss Smt GmbH | GASSEN, CHRISTOPHER J | 2881 | §103 | Final Rejection | 12d | Pending | Jul 11, 2023 |
| 18271250 | METHODS AND COMPOSITIONS FOR MODULATING THE INTERACTION BETWEEN ADENO-ASSOCIATED VIRUS (AAV) AND THE AAV RECEPTOR (AAVR) FOR ALTERED BIO-DISTRIBUTION OF AAV | The Schepens Eye Research Institute, Inc. | HILL, MYRON G | 1671 | §103 | Non-Final OA | 22d | Pending | Jul 07, 2023 |
| 18346975 | ANTI-HLA-DQ2.5 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE | Chugai Seiyaku Kabushiki Kaisha | BRISTOL, LYNN ANNE | 1643 | Other | Non-Final OA | 15d overdue | Pending | Jul 05, 2023 |
| 18271026 | NATURAL KILLER CELLS ENGINEERED TO REDUCE OR ELIMINATE CBL-B AND USES THEREOF | City Of Hope | SUNSHINE, HANNAH LOUISE | 1647 | §103 | Non-Final OA | 48d | Pending | Jul 05, 2023 |
| 18268167 | EXPANDED AND STIMULATED NATURAL KILLER CELLS | Gc Cell Corporation | PAULUS, ERIN VIRGINIA | 1631 | Other | Non-Final OA | 88d overdue | Pending | Jun 16, 2023 |
| 18256739 | Targeting Trancranial Magnetic Stimulation to Specific Brain Regions and Evaluating the Reduction of Symptoms of Psychotic Disorders | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | HOFFA, ANGELA MARIE | 3799 | §112 | Non-Final OA | 9d | Pending | Jun 09, 2023 |
| 18208140 | METHODS FOR DETECTING MUTATIONS IN TARGET NUCLEIC ACIDS USING DUAL PROBES | Revvity Health Sciences, Inc. | DAUNER, JOSEPH G | 1682 | §103 | Non-Final OA | 13d | Pending | Jun 09, 2023 |
| 18266443 | COMPOSITIONS AND USES OF CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE CELLS | City Of Hope | BENAVIDES, JENNIFER ANN | 1675 | §103 | Non-Final OA | 70d | Pending | Jun 09, 2023 |
| 18206184 | METHODS FOR PREDICTING AN ACTIVE SET OF COMPOUNDS HAVING ALTERNATIVE CORES, AND DRUG DISCOVERY METHODS INVOLVING THE SAME | Schrödinger, Inc. | NGUYEN, LAM S | 2853 | §103 | Non-Final OA | 7d | Pending | Jun 06, 2023 |
| 18038423 | COMPOSITIONS AND USES OF PSCA TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS | City Of Hope | FAUST, AMBER KATHLEEN | 1643 | Other | Non-Final OA | 42d overdue | Pending | May 23, 2023 |
| 18038101 | ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS | The Regents of the University of California | FAUST, AMBER KATHLEEN | 1643 | §103 | Non-Final OA | 34d | Pending | May 22, 2023 |
| 18198404 | METHODS OF TREATING CANCER USING LSD1 INHIBITORS IN COMBINATION WITH IMMUNOTHERAPY | President and Fellows of Harvard College | BUTTICE, AUDREY L | 1647 | Other | Non-Final OA | 16d overdue | Pending | May 17, 2023 |
| 18036579 | PROBES, SYSTEMS, AND METHODS FOR MAGNETIC RESONANCE PH SENSING | The General Hospital Corporation | JONES, DAMERON LEVEST | 1618 | §102 | Non-Final OA | 26d overdue | Pending | May 11, 2023 |
| 18144125 | STRUCTURED MEDICAL DATA CLASSIFICATION SYSTEM FOR MONITORING AND REMEDIATING TREATMENT RISKS | Carnegie Mellon University | ABDULLAH, AAISHA | 3681 | §103 | Final Rejection | 14d | Pending | May 05, 2023 |
| 18035174 | THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF | The General Hospital Corporation | PEEBLES, KATHERINE | 1617 | Other | Final Rejection | 42d | Pending | May 03, 2023 |
| 18142360 | PISTON FOR WIND INSTRUMENTS | Conn-Selmer, Inc. | LOCKETT, KIMBERLY R | 2837 | §103 | Non-Final OA | — | Pending | May 02, 2023 |
| 18141530 | Polishing Compositions and Methods of Using Same | Fujifilm Electronic Materials U.S.A., Inc. | LU, JIONG-PING | 1713 | §103 | Final Rejection | 14d | Pending | May 01, 2023 |
| 18304266 | DEVICE AND METHOD FOR PREPARING MICROSCOPIC SAMPLES | Carl Zeiss Microscopy GmbH | LOGIE, MICHAEL J | 2881 | §103 | Non-Final OA | 21d | Pending | Apr 20, 2023 |
| 18029323 | TOPICAL OPHTHALMOLOGICAL COMPOSITIONS | Ads Therapeutics LLC | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Non-Final OA | 5d overdue | Pending | Mar 29, 2023 |
| 18127053 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | Fujifilm Electronic Materials U.S.A., Inc. | DUCLAIR, STEPHANIE P. | 1713 | §103 | Final Rejection | 93d overdue | Pending | Mar 28, 2023 |
| 18190425 | Immunologic Treatment of Cancer | Immunsys, Inc. | OUSPENSKI, ILIA I | 1644 | Other | Non-Final OA | 59d overdue | Pending | Mar 27, 2023 |
| 18025763 | Methods of Determining Immune Response | The Queensland Institute of Medical Research | EMCH, GREGORY S | 1678 | §102 | Non-Final OA | 66d overdue | Pending | Mar 10, 2023 |
| 18178675 | Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing | The General Hospital Corporation | ARON, KIMBERLY A | 1633 | Other | Non-Final OA | 15d | Pending | Mar 06, 2023 |
| 18024623 | RHO KINASE INHIBITION FOR TREATMENT OF PROLIFERATIVE VITREORETINOPATHY AND CONDITIONS ASSOCIATED WITH EPITHELIAL TO MESENCHYMAL TRANSITION | The Schepens Eye Research Institute, Inc. | WARD, PAUL V | 1622 | §102 | Non-Final OA | 91d overdue | Pending | Mar 03, 2023 |
| 18023536 | NOVEL CELL LINES, METHODS OF PRODUCING NATURAL KILLER CELLS AND USES THEREOF | City Of Hope | LUNDE, GRACE HENRY | 1641 | Other | Non-Final OA | 34d | Pending | Feb 27, 2023 |
| 18023564 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF USE THEREOF | Cureport Inc. | NGUYEN, NGOC-ANH THI | 1615 | §103 | Non-Final OA | 73d overdue | Pending | Feb 27, 2023 |
| 18023246 | PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF DIALYSIS PRURITUS CONTAINING IL-31 ANTAGONIST AS ACTIVE INGREDIENT | Chugai Seiyaku Kabushiki Kaisha | LANDSMAN, ROBERT S | 1647 | §103 | Non-Final OA | 124d overdue | Pending | Feb 24, 2023 |
| 18019720 | Human XIST Antisense Oligonucleotides for X Reactivation Therapy | The General Hospital Corporation | CHONG, KIMBERLY | 1636 | Other | Non-Final OA | 27d | Pending | Feb 03, 2023 |
| 18104406 | Rules-Based Ride Security | Zemcar, Inc. | KARIKARI, KWASI | 2641 | §103 | Final Rejection | 3d overdue | Pending | Feb 01, 2023 |
| 18018807 | PHARMACEUTICAL COMPOSITION COMPRISING CELL EXPRESSING CHIMERIC RECEPTOR | Yamaguchi University | AEDER, SEAN E | 1642 | §103 | Non-Final OA | 23d overdue | Pending | Jan 30, 2023 |
| 18014947 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Peptide Epitopes | The Brigham And Women`S Hospital, Inc. | WANG, RUIXUE | 1672 | §103 | Non-Final OA | 19d overdue | Pending | Jan 06, 2023 |
| 18093470 | SUBWOOFER AND FOOT PEDAL MECHANISM FOR DIGITAL PIANO | Steinway Musical Instruments, Inc. | SCHREIBER, CHRISTINA MARIE | 2837 | §103 | Non-Final OA | 24d overdue | Pending | Jan 05, 2023 |
| 18091296 | ELECTRONIC PIANO PEDAL WITH TACTILE RESPONSE | Steinway Musical Instruments, Inc. | DONELS, JEFFREY | 2837 | §103 | Non-Final OA | 26d overdue | Pending | Dec 29, 2022 |
| 18013155 | COMPOUNDS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | University of Delhi | WILSON, JERICA KATLYNN | 1621 | §103 | Final Rejection | 19d overdue | Pending | Dec 27, 2022 |
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | The Brigham And Women`S Hospital, Inc. | MARCSISIN, ELLEN JEAN | 1677 | Other | Non-Final OA | 8d overdue | Pending | Dec 21, 2022 |
| 18011637 | Combination Verapamil and Mometasone Therapy for the treatment of Chronic Rhinosinusitis | Massachusetts Eye And Ear Infirmary | LADD, CAROLYN LOUISE | 1622 | §103 | Non-Final OA | 86d | Pending | Dec 20, 2022 |
| 18010695 | TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM | The General Hospital Corporation | FETTEROLF, BRANDON J | 1626 | §103 | Non-Final OA | 160d overdue | Pending | Dec 15, 2022 |
| 18072947 | Universal Wall Boundary Condition Treatment for K-Omega Turbulence Models | DASSAULT SYSTEMES | HANN, JAY B | 2186 | §101 | Non-Final OA | 7d | Pending | Dec 01, 2022 |
| 17927827 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | Giiant Pharma Inc. | LEE, HOI YAN NMN | 1693 | §103 | Non-Final OA | 9d | Pending | Nov 25, 2022 |
| 17927796 | TOPICAL OPHTHALMOLOGICAL COMPOSITIONS AND METHODS FOR TREATING ABNORMAL ANGIOGENESIS | Ads Therapeutics LLC | FAY, ZOHREH ALEMZADEH | 1617 | §103 | Final Rejection | 27d | Pending | Nov 25, 2022 |
| 17927642 | Gasdermin D (GSDMD) Succination for the Treatment of Inflammatory Disease | UNIVERSITY OF MASSACHUSETTS | HAVLIN, ROBERT H | 1626 | §103 | Final Rejection | 34d | Pending | Nov 23, 2022 |
| 17926673 | IMPROVED GRANZYME B VARIANT | Chugai Seiyaku Kabushiki Kaisha | PATTERSON, SARAH COOPER | 1675 | §103 | Non-Final OA | 11d overdue | Pending | Nov 21, 2022 |
| 17989195 | METHOD FOR FOCUSING AND OPERATING A PARTICLE BEAM MICROSCOPE | Carl Zeiss Microscopy GmbH | CHOI, JAMES J | 2878 | §103 | Non-Final OA | 2d overdue | Pending | Nov 17, 2022 |
| 17925918 | ELECTROCHEMICAL SYNTHESIS OF METAL SUPERHYDRIDES | Carnegie Mellon University | CONTRERAS, CIEL P | 1794 | §112 | Non-Final OA | 11d overdue | Pending | Nov 17, 2022 |
| 17987432 | Rapidly Cooling Food and Drinks | Coldsnap, Corp. | AMIN, HAMZEH HICHAM | 3761 | §103 | Non-Final OA | 140d overdue | Pending | Nov 15, 2022 |
| 17986357 | SEQUENCING OF DNA BY SEQUENTIAL ADDITION/INCORPORATION OF 3` UNPROTECTED LABELED NUCLEOTIDES | Miltenyi Biotec B.V. & Co. KG | GRAY, JESSICA | 1682 | §103 | Final Rejection | 34d | Pending | Nov 14, 2022 |
| 17983220 | PARTICLE BEAM SYSTEM WITH MULTI-SOURCE SYSTEM AND MULTI-BEAM PARTICLE MICROSCOPE | Carl Zeiss Multisem GmbH | TANDY, LAURA ELOISE | 2881 | §103 | Non-Final OA | 110d overdue | Pending | Nov 08, 2022 |
| 17923838 | Translation Blockers Repurposed for COVID-19 Therapy | The General Hospital Corporation | ANDERSON, JAMES D | 1629 | §102 | Non-Final OA | 72d overdue | Pending | Nov 07, 2022 |
| 17981702 | Induction Coil Assembly for Uterine Ablation and Method | Aegea Medical Inc. | VAN, QUANG T | 3761 | §103 | Non-Final OA | 140d overdue | Pending | Nov 07, 2022 |
| 17974944 | Biomaterial for Articular Cartilage Maintenance and Treatment of Arthritis | Rhode Island Hospital | SCHUBERG, LAURA J | 1631 | Other | Final Rejection | 38d overdue | Pending | Oct 27, 2022 |
| 17970667 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | Fujifilm Electronic Materials U.S.A., Inc. | CASE, SARAH CATHERINE | 1731 | §103 | Non-Final OA | 30d | Pending | Oct 21, 2022 |
| 17919848 | Fluorinated Derivatives of Gabapentin and Methods of Use Thereof | The General Hospital Corporation | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 29d overdue | Pending | Oct 19, 2022 |
| 17967930 | Methods of Calibrating a Blood Flow Monitoring Device, Methods of Monitoring Blood Flow, and Blood Flow Monitoring Systems | Coopersurgical, Inc. | SULTANA, DILARA | 2858 | §102 | Non-Final OA | 45d overdue | Pending | Oct 18, 2022 |
| 17919178 | FLT3-TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS FOR TREATMENT OF FLT3-POSITIVE MALIGNANCIES | City Of Hope | REDDIG, PETER J | 1646 | §103 | Final Rejection | 8d overdue | Pending | Oct 14, 2022 |
| 17914855 | IMMUNE ACTIVATING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF | Chugai Seiyaku Kabushiki Kaisha | DRISCOLL, MAUREEN VARINA | 1644 | §102 | Non-Final OA | 105d overdue | Pending | Sep 27, 2022 |
| 17914432 | METHOD FOR PRODUCING MULTISPECIFIC ANTIGEN-BINDING MOLECULES | Chugai Seiyaku Kabushiki Kaisha | BRISTOL, LYNN ANNE | 1643 | Other | Non-Final OA | 9d overdue | Pending | Sep 26, 2022 |
| 17912272 | TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3 | The General Hospital Corporation | FETTEROLF, BRANDON J | 1626 | Other | Non-Final OA | 7d | Pending | Sep 16, 2022 |
| 17910459 | DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISING IL-13 AND CHLOROTOXIN FOR CANCER TREATMENT | City Of Hope | HILL, KEVIN KAI | 1638 | §103 | Non-Final OA | 9d overdue | Pending | Sep 09, 2022 |
| 17908810 | METHODS AND SYSTEMS TO PRINT AND MATURE TISSUES OVER TIME IN A THREE-DIMENSIONAL SUPPORT MATRIX | The General Hospital Corporation | NGUYEN, NGHI V | 1653 | §103 | Non-Final OA | 80d overdue | Pending | Sep 01, 2022 |
| 17907781 | SELECTIVE MODULATION OF TRANSFORMING GROWTH FACTOR BETA SUPERFAMILY SIGNALING VIA MULTI-SPECIFIC ANTIBODIES | The Brigham And Women'S Hospital, Inc. | BRISTOL, LYNN ANNE | 1643 | §112 | Final Rejection | 53d | Pending | Aug 29, 2022 |
| 17904485 | HERBAL PREPARATION FOR PREVENTION AND TREATMENT OF HELICOBACTER PYLORI INFECTION | Herbelixa Doo Sremska Kamenica | CAIN, JENNIFER LYNN | 1655 | §103 | Non-Final OA | 44d overdue | Pending | Aug 18, 2022 |
| 17799164 | MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION | The General Hospital Corporation | GABEL, GAILENE | 1678 | §102 | Non-Final OA | 14d | Pending | Aug 11, 2022 |
| 17869388 | METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS | The McLean Hospital Corporation | BEANE, RANDALL L | 1654 | §112 | Final Rejection | 28d | Pending | Jul 20, 2022 |
| 17790535 | MICROFLUIDIC SYSTEMS AND METHODS FOR LOW-SHEAR ISOLATION OF RARE CELLS FROM LARGE SAMPLE VOLUMES | The General Hospital Corporation | HERON, VELVET ELIZABETH | 1798 | §103 | Final Rejection | 55d | Pending | Jul 01, 2022 |
| 17789930 | METHODS OF MAKING AND USING REGULATORY T CELLS AND EFFECTOR T CELLS HAVING CHIMERIC ANTIGEN RECEPTORS TARGETED TO CD6, CD19, AND/OR AN IL-13R FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS | City Of Hope | BELYAVSKYI, MICHAIL A | 1644 | Other | Non-Final OA | 16d overdue | Pending | Jun 29, 2022 |
| 17849272 | Coupler Device for Round Window Stimulation of the Cochlea | UNIVERSITÄT BASEL | KOHUTKA, BROOKE NICOLE | 3791 | §103 | Final Rejection | 6d | Pending | Jun 24, 2022 |
| 17788163 | Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease | Proqr Therapeutics Ii B.V. | VANHORN, ABIGAIL LOUISE | 1636 | Other | Final Rejection | 28d | Pending | Jun 22, 2022 |
| 17842647 | Rare Sugars in Food and Beverage Products | Ocean Spray Cranberries, Inc. | LACHICA, ERICSON M | 1792 | §103 | Non-Final OA | 3d overdue | Pending | Jun 16, 2022 |
| 17786154 | TREATING HEART DISEASE IN MUSCULAR DYSTROPHY PATIENTS | Children`S Medical Center Corporation | SCHMITT, MICHAEL J | 1629 | §103 | Final Rejection | 33d | Pending | Jun 16, 2022 |
| 17757402 | RETRO-INVERSO PEPTIDES | Herantis Pharma Oyj | STEELE, AMBER D | 1658 | §103 | Non-Final OA | 8d overdue | Pending | Jun 15, 2022 |
| 17782369 | COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLES | The General Hospital Corporation | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | 3d overdue | Pending | Jun 03, 2022 |
| 17781646 | Multi-Biomarker Prediction Models for Multiple Infection Episodes Following Blunt Trauma | Shriners Hospitals For Children | HANEY, AMANDA MARIE | 1682 | §103 | Non-Final OA | 87d overdue | Pending | Jun 01, 2022 |
| 17752966 | Compositions and Methods for Treating Cancer with DuoCARs | Lentigen Technology, Inc. | MARVICH, MARIA | 1634 | Other | Final Rejection | 51d overdue | Pending | May 25, 2022 |
| 17777659 | STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY | Children'S Medical Center Corporation | CHATTIN, AMY MARIE | 1643 | §103 | Non-Final OA | 91d overdue | Pending | May 18, 2022 |
| 17777550 | Hyperactive Dendritic Cells Enable Durable Adoptive Cell Transfer-Based Anti-Tumor Immunity | Children'S Medical Center Corporation | JUEDES, AMY E | 1644 | §103 | Final Rejection | 70d overdue | Pending | May 17, 2022 |
| 17774088 | GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF | City Of Hope | WESTON, ALYSSA G | 1633 | §102 | Final Rejection | 60d overdue | Pending | May 03, 2022 |
| 17773273 | METHODS OF ANALYZING A BIOLOGICAL SAMPLE | Wallac OY | SITTON, JEHANNE SOUAYA | 1682 | §103 | Non-Final OA | 4d overdue | Pending | Apr 29, 2022 |
| 17771982 | ANTIBODIES FOR BINDING PLASMINOGEN | Monash University | TAYLOR, LIA ELAN | 1641 | §112 | Non-Final OA | 15d | Pending | Apr 26, 2022 |
| 17772017 | Gene Therapy Approaches to Mucolipidosis IV (MLIV) | The General Hospital Corporation | PENNINGTON, KATIE LEIGH | 1634 | §102 | Final Rejection | 51d overdue | Pending | Apr 26, 2022 |
| 17769626 | MONOLAYER CELL PATCH IN AN EXTRACELLULAR MATRIX SCAFFOLD | Carnegie Mellon University | XU, QING | 1656 | §103 | Final Rejection | 45d overdue | Pending | Apr 15, 2022 |
| 17766445 | OCULAR SEALANTS AND METHODS OF USING THE SAME | The Regents of the University of California | PHAN, DOAN THI-THUC | 1613 | Other | Non-Final OA | 28d | Pending | Apr 04, 2022 |
| 17699655 | POLISHING COMPOSITIONS AND METHODS OF USING THE SAME | Fujifilm Electronic Materials U.S.A., Inc. | DUCLAIR, STEPHANIE P. | 1713 | §103 | Non-Final OA | 44d overdue | Pending | Mar 21, 2022 |
| 17698617 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | The Brigham And Women`S Hospital, Inc. | WU, JULIE ZHEN QIN | 1644 | §103 | Non-Final OA | 22d | Pending | Mar 18, 2022 |
| 17642986 | METHODS FOR DEPLETION OF DELETERIOUS MITOCHONDRIAL GENOMES | UNIVERSITY OF MASSACHUSETTS | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | 1d overdue | Pending | Mar 15, 2022 |
| 17640889 | METHODS FOR ALLEVIATING PTERYGIUM-ASSOCIATED WORRY ABOUT EYE APPEARANCE | Cloudbreak Therapeutics, LLC | HUANG, GIGI GEORGIANA | 1613 | Other | Non-Final OA | 34d | Pending | Mar 07, 2022 |
| 17638543 | Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned tumor Array Devices | The General Hospital Corporation | KWAK, DEAN P | 1798 | §103 | Final Rejection | 8d overdue | Pending | Feb 25, 2022 |
| 17636272 | SINGLE-CELL MODELING OF CLINICAL DATA TO DETERMINE RED BLOOD CELL REGULATION | The General Hospital Corporation | VASSELL, MEREDITH ABBOTT | 1687 | §103 | Non-Final OA | 85d overdue | Pending | Feb 17, 2022 |
| 17586991 | BEAM MACHINING PLATE-LIKE OR TUBULAR WORKPIECES | Wsoptics Technologies GmbH | ECKARDT, ADAM MICHAEL | 3761 | §103 | Non-Final OA | 38d overdue | Pending | Jan 28, 2022 |
| 17626728 | ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF | The General Hospital Corporation | BEHARRY, ZANNA MARIA | 1632 | §103 | Non-Final OA | 9d overdue | Pending | Jan 12, 2022 |
| 17624516 | COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES | Ads Therapeutics LLC | BAKSHI, PANCHAM | 1623 | §102 | Final Rejection | 154d overdue | Pending | Jan 03, 2022 |
| 17621744 | INTUBATION DEVICE IMPROVEMENTS | Airway Medical Innovations Pty Ltd | HOWELL, GWYNNETH LINNEA | 3785 | §103 | Final Rejection | 9d overdue | Pending | Dec 22, 2021 |
| 17554690 | System for Identifying Structures of Molecular Compounds from Mass Spectrometry Data | Carnegie Mellon University | KALLAL, ROBERT JAMES | 1685 | §112 | Final Rejection | 9d | Pending | Dec 17, 2021 |
| 17619783 | Specific Nuclear-Anchored Independent Labeling System | Carnegie Mellon University | RIGGS II, LARRY D | 1686 | §103 | Non-Final OA | 141d overdue | Pending | Dec 16, 2021 |
| 17618273 | RENAL CLEARABLE FLUORESCENT CONTRAST AGENT WITH INCREASED TUMOR SPECIFICITY, AND IMAGING METHOD USING SAME | Nawoovision Co., Ltd. | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | 85d overdue | Pending | Dec 10, 2021 |
| 17618333 | ANTIBIOTIC COMPOUNDS | Emory University | HABTE, KAHSAY | 1624 | §102 | Non-Final OA | 67d overdue | Pending | Dec 10, 2021 |
| 17617490 | ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS | President and Fellows of Harvard College | MARVICH, MARIA | 1634 | §103 | Final Rejection | 92d overdue | Pending | Dec 08, 2021 |
| 17617173 | Fe-Ni Nanocomposite Alloys | Carnegie Mellon University | HILL, STEPHANI A | 1735 | §103 | Final Rejection | 78d overdue | Pending | Dec 07, 2021 |
| 17615748 | ANTIBODY CLEAVAGE SITE BINDING MOLECULE | Yamaguchi University | CANELLA, KAREN A | 1643 | §112 | Final Rejection | 52d overdue | Pending | Dec 01, 2021 |
| 17613467 | A THERAPEUTIC APPROACH FOR TREATING NON-INFECTIOUS OCULAR IMMUNOINFLAMMATORY DISORDERS | The Schepens Eye Research Institute, Inc. | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | 10d overdue | Pending | Nov 22, 2021 |
| 17520402 | CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN | City Of Hope | HINES, JANA A | 1645 | §103 | Non-Final OA | 110d overdue | Pending | Nov 05, 2021 |
| 17609181 | METHOD TO INDUCE HEMATOPOIETIC CHIMERISM | The General Hospital Corporation | PENNINGTON, KATIE LEIGH | 1634 | §103 | Final Rejection | 99d overdue | Pending | Nov 05, 2021 |
| 17603646 | AEROSOLIZED COMPOSITIONS COMPRISING MITOCHONDRIA AND METHODS OF USE THEREOF | Children`S Medical Center Corporation | SIPPEL, RACHEL T | 3785 | §103 | Final Rejection | 33d | Pending | Oct 14, 2021 |
| 17498813 | Dielectric Film-Forming Composition | Fujifilm Electronic Materials U.S.A., Inc. | MCCULLEY, MEGAN CASSANDRA | 1767 | §103 | Non-Final OA | 3d overdue | Pending | Oct 12, 2021 |
| 17601522 | AIM2 INHIBITORS AND USES THEREOF | UNIVERSITY OF MASSACHUSETTS | TRAN, CHRISTINA L | 1637 | §103 | Non-Final OA | 4d overdue | Pending | Oct 05, 2021 |
| 17598358 | ENDOSCOPIC DEVICES AND RELATED METHODS | Coopersurgical, Inc. | LUU, TIMOTHY TUAN | 3795 | Other | Non-Final OA | 28d | Pending | Sep 27, 2021 |
| 17438993 | ANTIGEN-BINDING MOLECULE CONTAINING ANTIGEN-BINDING DOMAIN OF WHICH BINDING ACTIVITY TO ANTIGEN IS CHANGED DEPENDING ON MTA, AND LIBRARY FOR OBTAINING SAID ANTIGEN-BINDING DOMAIN | Chugai Seiyaku Kabushiki Kaisha | SKOKO III, JOHN JOSEPH | 1643 | §112 | Non-Final OA | 114d overdue | Pending | Sep 14, 2021 |
| 17438496 | ANTI-HLA-DQ2.5 ANTIBODY | Chugai Seiyaku Kabushiki Kaisha | DIBRINO, MARIANNE | 1641 | Other | Non-Final OA | 119d overdue | Pending | Sep 13, 2021 |
| 17434349 | TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM | The General Hospital Corporation | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Non-Final OA | 50d overdue | Pending | Aug 26, 2021 |
| 17430822 | Treating Heart Failure | Children`S Medical Center Corporation | BEHARRY, ZANNA MARIA | 1632 | Other | Non-Final OA | 100d overdue | Pending | Aug 13, 2021 |
| 17428593 | PRESERVATION OF VASCULARIZED COMPOSITE ALLOGRAFTS | The General Hospital Corporation | BEHARRY, ZANNA MARIA | 1632 | Other | Final Rejection | 31d overdue | Pending | Aug 04, 2021 |
| 17376664 | INTERACTIVE AND ITERATIVE TRAINING OF A CLASSIFICATION ALGORITHM FOR CLASSIFYING ANOMALIES IN IMAGING DATASETS | Carl Zeiss Smt GmbH | WU, NICHOLAS S | 2148 | §103 | Non-Final OA | 112d overdue | Pending | Jul 15, 2021 |
| 17418343 | ANTI-EPHRIN-B2 BLOCKING ANTIBODIES FOR THE TREATMENT OF FIBROTIC DISEASES | The General Hospital Corporation | MELCHIOR, JAMES RYLAND | 1644 | §103 | Final Rejection | 86d overdue | Pending | Jun 25, 2021 |
| 17291922 | An lncRNA integrates a DNA-PK-mediated DNA damage response and vascular senescence | The Brigham And Women`S Hospital, Inc. | MCKILLOP, JOHN CHARLES | 1637 | §103 | Non-Final OA | 28d | Pending | May 06, 2021 |
| 17285743 | Bioadhesive for Soft Tissue Repair | Northeastern University | CHANG, KYUNG SOOK | 1613 | Other | Final Rejection | 29d | Pending | Apr 15, 2021 |
| 17284919 | The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy | The Brigham And Women`S Hospital, Inc. | TRAN, CHRISTINA L | 1637 | §112 | Final Rejection | 37d overdue | Pending | Apr 13, 2021 |
| 17270711 | The Microbiome as a Target of MicroRNAs for the Treatment of Disease | The Brigham And Women'S Hospital, Inc. | ZAHORIK, AMANDA MARY | 1636 | §103 | Final Rejection | 38d overdue | Pending | Feb 23, 2021 |
| 17040661 | METHOD FOR PRODUCING NATURAL KILLER CELLS | Gc Cell Corporation | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Final Rejection | 67d overdue | Pending | Jan 14, 2021 |
| 17144342 | ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS | Chugai Seiyaku Kabushiki Kaisha | SANG, HONG | 1646 | §112 | Non-Final OA | 53d overdue | Pending | Jan 08, 2021 |
| 17011088 | Method and Apparatus for Automatic Underhood Thermal Modeling | DASSAULT SYSTEMES | COOK, BRIAN S | 2187 | §103 | Non-Final OA | 27d | Pending | Sep 03, 2020 |
| 16735146 | Multiplex Guide RNAS | The General Hospital Corporation | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103 | Non-Final OA | 97d overdue | Pending | Jan 06, 2020 |
| 16692676 | ANTIGEN-BINDING MOLECULE HAVING REGULATED CONJUGATION BETWEEN HEAVY-CHAIN AND LIGHT-CHAIN | Chugai Seiyaku Kabushiki Kaisha | BRISTOL, LYNN ANNE | 1643 | Other | Final Rejection | 104d overdue | Pending | Nov 22, 2019 |
| 16193272 | Collateral Mechanisms Using High Quality Redeemable Notes | Risconsulting Group LLC, The | SCHWARZENBERG, PAUL | 3695 | §101 | Non-Final OA | 27d | Pending | Nov 16, 2018 |
| 15032963 | Magnetic Disk of a Data Storage Device with Templated Growth of Magnetic Recording Layer | Carnegie Mellon University | RICKMAN, HOLLY C | 1785 | §103 | Non-Final OA | 46d overdue | Pending | Apr 28, 2016 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial